Literature DB >> 29629498

Multifocal alterations of white matter accompany the transition from normal cognition to dementia in Parkinson's disease patients.

Maria Chondrogiorgi1, Loukas G Astrakas2, Anastasia K Zikou3, Luca Weis4, Vassilios G Xydis3, Angelo Antonini4, Maria I Argyropoulou3, Spiridon Konitsiotis5.   

Abstract

The purpose of the present study was to investigate the pattern of white matter (WM) changes associated with Parkinson's disease (PD)-related cognitive impairment by using fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity (AD) and radial diffusivity (RD) measures. Diffusion Tensor Imaging (DTI) was performed in 21 PD-patients with dementia (PDD) and in an age-matched control group including 40 PD-patients without dementia (PD-CTRL). The Parkinson's disease-Cognitive Rating Scale (PD-CRS) was used for patients' neuropsychological assessment. Local microstructural WM differences associated with the presence of cognitive impairment were tested using tract-based spatial statistics analysis. Multiple regression models investigated the association of DTI indices with total PD-CRS score, PD-CRS raw items and other clinical measures across the whole study sample. Significant FA decreases were found in PDD compared to PD-CTRL patients mainly in the body of corpus callosum, corona radiata and cingulum. Lower PD-CRS score was significantly associated with decreased FA, MD and AD values in multiple WM tracts primarily located in prefrontal and limbic areas as well as across the corpus callosum. Lower performance in specific PD-CRS raw items was also associated with FA decreases in major WM tracts. The results suggest that multifocal microstructural changes of WM accompany the transition from normal to demented cognitive state in PD-patients. The corpus callosum, the corona radiata and the cingulum are among the regions mostly affected during this course. A progressive axonal degeneration is proposed as a key underlying mechanism.

Entities:  

Keywords:  Axial diffusivity; Diffusion tensor imaging; MRI; Parkinson’s disease dementia; Tract-based spatial statistics

Mesh:

Year:  2019        PMID: 29629498     DOI: 10.1007/s11682-018-9863-7

Source DB:  PubMed          Journal:  Brain Imaging Behav        ISSN: 1931-7557            Impact factor:   3.978


  7 in total

Review 1.  Morphological basis of Parkinson disease-associated cognitive impairment: an update.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2022-06-20       Impact factor: 3.850

Review 2.  Cerebellar Microstructural Abnormalities in Parkinson's Disease: a Systematic Review of Diffusion Tensor Imaging Studies.

Authors:  Maryam Haghshomar; Parnian Shobeiri; Seyed Arsalan Seyedi; Fatemeh Abbasi-Feijani; Amirhossein Poopak; Houman Sotoudeh; Arash Kamali; Mohammad Hadi Aarabi
Journal:  Cerebellum       Date:  2022-01-10       Impact factor: 3.648

3.  Structural brain signature of cognitive decline in Parkinson's disease: DTI-based evidence from the LANDSCAPE study.

Authors:  Martin Gorges; Hans-Peter Müller; Inga Liepelt-Scarfone; Alexander Storch; Richard Dodel; Rüdiger Hilker-Roggendorf; Daniela Berg; Martin S Kunz; Elke Kalbe; Simon Baudrexel; Jan Kassubek
Journal:  Ther Adv Neurol Disord       Date:  2019-05-16       Impact factor: 6.570

4.  White Matter Abnormalities in Patients With Parkinson's Disease: A Meta-Analysis of Diffusion Tensor Imaging Using Tract-Based Spatial Statistics.

Authors:  Xia Wei; Chunyan Luo; Qian Li; Na Hu; Yuan Xiao; Nian Liu; Su Lui; Qiyong Gong
Journal:  Front Aging Neurosci       Date:  2021-01-28       Impact factor: 5.750

5.  Digital sleep measures and white matter health in the Framingham Heart Study.

Authors:  Robert Joseph Thomas; Hyun Kim; Pauline Maillard; Charles S DeCarli; Eric James Heckman; Cody Karjadi; Ting Fang Alvin Ang; Rhoda Au
Journal:  Explor Med       Date:  2021-06-30

Review 6.  Prospective memory impairment in neurological disorders: implications and management.

Authors:  Julie D Henry
Journal:  Nat Rev Neurol       Date:  2021-03-08       Impact factor: 42.937

7.  Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure.

Authors:  Farzaneh Ghazi Sherbaf; Bahram Mohajer; Amir Ashraf-Ganjouei; Mahtab Mojtahed Zadeh; Ali Javinani; Hossein Sanjari Moghaddam; Mehdi Shirin Shandiz; Mohammad Hadi Aarabi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-11-02       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.